SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination

被引：20
|
作者：
Behrens, Georg M. N. [1 ,2 ]
Cossmann, Anne [1 ]
Stankov, Metodi V. [1 ]
Nehlmeier, Inga [3 ]
Kempf, Amy [3 ]
Hoffmann, Markus [3 ,4 ]
Poehlmann, Stefan [3 ,4 ]
机构：
[1] Hannover Med Sch, Dept Rheumatol & Immunol, D-30625 Hannover, Germany
[2] German Ctr Infect Res, Partner Site Hannover Braunschweig, Hannover, Germany
[3] Leibniz Inst Primate Res, Infect Biol Unit, German Primate Ctr, Gottingen, Germany
[4] Georg August Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany
来源：
LANCET | 2021年 / 398卷 / 10305期
关键词：
D O I：
10.1016/S0140-6736(21)01891-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1041 / 1042
页数：3
相关论文
共 50 条
  • [21] Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection
    Alfaleh, Amjad
    Alkattan, Abdullah
    Alzaher, Abrar
    Radwan, Nashwa
    Mahmoud, Nagla
    Alageel, Alaa
    Alhabib, Dina
    Alsalameen, Eman
    Sagor, Khlood
    Haji, Alhan
    Alfaifi, Amal
    Alabdulkareem, Khaled
    Ibrahim, Mona
    CLINICAL DRUG INVESTIGATION, 2022, 42 (10) : 799 - 806
  • [22] Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection
    Amjad Alfaleh
    Abdullah Alkattan
    Abrar Alzaher
    Nashwa Radwan
    Nagla Mahmoud
    Alaa Alageel
    Dina Alhabib
    Eman Alsalameen
    Khlood Sagor
    Alhan Haji
    Amal Alfaifi
    Khaled Alabdulkareem
    Mona Ibrahim
    Clinical Drug Investigation, 2022, 42 : 799 - 806
  • [23] Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
    Ko, Geon Young
    Lee, Jihyun
    Bae, Hyunjoo
    Ryu, Ji Hyeong
    Park, Hye-Sun
    Kang, Hyunhye
    Jung, Jin
    Choi, Ae-Ran
    Lee, Raeseok
    Lee, Dong-Gun
    Oh, Eun-Jee
    VACCINES, 2023, 11 (10)
  • [24] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
    Cheng, Samuel M. S.
    Mok, Chris Ka Pun
    Leung, Yonna W. Y.
    Ng, Susanna S.
    Chan, Karl C. K.
    Ko, Fanny W.
    Chen, Chunke
    Yiu, Karen
    Lam, Bosco H. S.
    Lau, Eric H. Y.
    Chan, Ken K. P.
    Luk, Leo L. H.
    Li, John K. C.
    Tsang, Leo C. H.
    Poon, Leo L. M.
    Hui, David S. C.
    Peiris, Malik
    NATURE MEDICINE, 2022, 28 (03) : 486 - +
  • [25] Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
    Samuel M. S. Cheng
    Chris Ka Pun Mok
    Yonna W. Y. Leung
    Susanna S. Ng
    Karl C. K. Chan
    Fanny W. Ko
    Chunke Chen
    Karen Yiu
    Bosco H. S. Lam
    Eric H. Y. Lau
    Ken K. P. Chan
    Leo L. H. Luk
    John K. C. Li
    Leo C. H. Tsang
    Leo L. M. Poon
    David S. C. Hui
    Malik Peiris
    Nature Medicine, 2022, 28 : 486 - 489
  • [26] SAEs after BNT162b2, CoronaVac and ChAdOx1 vaccination
    Reactions Weekly, 2022, 1911 (1) : 12 - 12
  • [27] Immune Responses Against SARS-CoV-2 WT and Delta Variant in Elderly BNT162b2 Vaccinees
    Jaeger, Michael
    Sonnleitner, Sissy Therese
    Dichtl, Stefanie
    Lafon, Eliott
    Diem, Gabriel
    Walder, Gernot
    Lass-Floerl, Cornelia
    Wilflingseder, Doris
    Posch, Wilfried
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Diminished T-cell immune responses to SARS-CoV-2 omicron variant after BNT162b2 vaccination
    Jordan, Stanley C.
    Shin, Bong-Ha
    Rodriguez, Edgar
    Vo, Ashley
    Ammerman, Noriko
    Zhang, Ruan
    IMMUNOLOGY LETTERS, 2022, 248 : 123 - 125
  • [29] Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
    Hyeryung Kwon
    Taewon Kim
    Neurological Sciences, 2022, 43 : 1487 - 1489
  • [30] Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination
    Kwon, Hyeryung
    Kim, Taewon
    NEUROLOGICAL SCIENCES, 2022, 43 (03) : 1487 - 1489
12345